BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10548745)

  • 21. Aldose reductase in diabetic cataracts.
    Kinoshita JH; Kador P; Catiles M
    JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
    [No Abstract]   [Full Text] [Related]  

  • 22. Drevogenin D prevents selenite-induced oxidative stress and calpain activation in cultured rat lens.
    Biju PG; Rooban BN; Lija Y; Devi VG; Sahasranamam V; Abraham A
    Mol Vis; 2007 Jul; 13():1121-9. PubMed ID: 17653057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effect of Trigonella foenum graecum and its combination with sodium orthovanadate in preventing histopathological and biochemical abnormalities in diabetic rat ocular tissues.
    Preet A; Siddiqui MR; Taha A; Badhai J; Hussain ME; Yadava PK; Baquer NZ
    Mol Cell Biochem; 2006 Sep; 289(1-2):137-47. PubMed ID: 16718375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between osmotic and oxidative stress in diabetic precataractous lens: studies with a sorbitol dehydrogenase inhibitor.
    Obrosova IG; Fathallah L; Lang HJ
    Biochem Pharmacol; 1999 Dec; 58(12):1945-54. PubMed ID: 10591149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of polyol pathway to diabetes-induced oxidative stress.
    Chung SS; Ho EC; Lam KS; Chung SK
    J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S233-6. PubMed ID: 12874437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antioxidant potential of fungal metabolite nigerloxin during eye lens abnormalities in galactose-fed rats.
    Suresha BS; Srinivasan K
    Curr Eye Res; 2013 Oct; 38(10):1064-71. PubMed ID: 23767695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF; Akagi Y; Kinoshita JH
    Metabolism; 1986 Apr; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H2S donors attenuate diabetic nephropathy in rats: Modulation of oxidant status and polyol pathway.
    Safar MM; Abdelsalam RM
    Pharmacol Rep; 2015 Feb; 67(1):17-23. PubMed ID: 25560570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
    Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lutein attenuates oxidative stress markers and ameliorates glucose homeostasis through polyol pathway in heart and kidney of STZ-induced hyperglycemic rat model.
    Sharavana G; Joseph GS; Baskaran V
    Eur J Nutr; 2017 Dec; 56(8):2475-2485. PubMed ID: 27488609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of expression of hexokinase, aldose reductase and sorbitol dehydrogenase genes in lens of mouse and rat.
    Wen Y; Bekhor I
    Curr Eye Res; 1993 Apr; 12(4):323-32. PubMed ID: 8319491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction: evidence for the role of the polyol pathway in the pathophysiology of diabetic complications.
    Beyer TA; Hutson NJ
    Metabolism; 1986 Apr; 35(4 Suppl 1):1-3. PubMed ID: 3083197
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduction of oxidative-nitrosative stress underlies anticataract effect of topically applied tocotrienol in streptozotocin-induced diabetic rats.
    Abdul Nasir NA; Agarwal R; Sheikh Abdul Kadir SH; Vasudevan S; Tripathy M; Iezhitsa I; Mohammad Daher A; Ibrahim MI; Mohd Ismail N
    PLoS One; 2017; 12(3):e0174542. PubMed ID: 28350848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
    Ao S; Kikuchi C; Ono T; Notsu Y
    Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical localization for aldose reductase in diabetic lenses.
    Akagi Y; Kador PF; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):163-7. PubMed ID: 3100473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat.
    Kubo E; Maekawa K; Tanimoto T; Fujisawa S; Akagi Y
    Exp Eye Res; 2001 Sep; 73(3):375-81. PubMed ID: 11520112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic effect of osmotic and oxidative stress in slow-developing cataract formation.
    Chan AW; Ho YS; Chung SK; Chung SS
    Exp Eye Res; 2008 Nov; 87(5):454-61. PubMed ID: 18760274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GP-1447, an inhibitor of aldose reductase, prevents the progression of diabetic cataract in rats.
    Kawakubo K; Mori A; Sakamoto K; Nakahara T; Ishii K
    Biol Pharm Bull; 2012; 35(6):866-72. PubMed ID: 22687477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reinvestigation of streptozotocin induced diabetic cataract as a standard experimental model].
    Kojima M; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1993 Mar; 97(3):324-32. PubMed ID: 8317349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.